Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Steven E McNulty"'
Autor:
Siddique A Abbasi, Ravi V Shah, Steven E McNulty, Adrian F Hernandez, Marc J Semigran, Gregory D Lewis, Michael Jerosch-Herold, Raymond J Kim, Margaret M Redfield, Raymond Y Kwong
Publikováno v:
PLoS ONE, Vol 11, Iss 11, p e0164914 (2016)
Given the emerging recognition of left atrial structure and function as an important marker of disease in heart failure with preserved ejection fraction (HF-pEF), we investigated the association between left atrial volume and function with markers of
Externí odkaz:
https://doaj.org/article/1f31a524981447a6a7aea3c488a47d3c
Autor:
Abhinav Sharma, Stephen Greene, Muthiah Vaduganathan, Marat Fudim, Andrew P. Ambrosy, Jie‐Lena Sun, Steven E. McNulty, Adrian F. Hernandez, Barry A. Borlaug, Eric J. Velazquez, Robert J. Mentz, Adam D. DeVore, Brooke Alhanti, Kenneth Margulies, G. Michael Felker
Publikováno v:
ESC Heart Failure, Vol 8, Iss 4, Pp 2608-2616 (2021)
Abstract Aims Associations between growth differentiation factor‐15 (GDF‐15), cardiovascular outcomes, and exercise capacity among patients with a recent hospitalization for heart failure (HHF) and heart failure with reduced ejection fraction (HF
Externí odkaz:
https://doaj.org/article/385af4f80c514fc69c535399a22fde82
Autor:
Justin M. Vader, Michael M. Givertz, Randall C. Starling, Steven E. McNulty, Kevin J. Anstrom, Patrice Desvigne-Nickens, Adrian F. Hernandez, Eugene Braunwald, Douglas L. Mann
Publikováno v:
JACC: Heart Failure. 10:449-456
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa33587cca08ce18196a806f90544147
https://doi.org/10.1016/j.jchf.2022.04.013
https://doi.org/10.1016/j.jchf.2022.04.013
Autor:
Jane, O'Halloran, Eyal, Kedar, Kevin J, Anstrom, Matthew W, McCarthy, Emily R, Ko, Patricia, Segura Nunez, Cynthia, Boucher, P Brian, Smith, Reynold A, Panettieri, Sabina, Mendivil Tuchia de Tai, Martin, Maillo, Akram, Khan, Alfredo J, Mena Lora, Matthias, Salathe, Gerardo, Capo, Daniel, Rodriguez Gonzalez, Thomas F, Patterson, Christopher, Palma, Horacio, Ariza, Maria, Patelli Lima, Anne M, Lachiewicz, John, Blamoun, Esteban, Nannini, Eduardo, Sprinz, Analia, Mykietiuk, Radica, Alicic, Adriana M, Rauseo, Cameron R, Wolfe, Britta, Wittig, Daniel K, Benjamin, Steven E, McNulty, Pearl, Zakroysky, Susan, Halabi, Sandra, Butler, Jane, Atkinson, Stacey J, Adam, Richard, Melsheimer, Soju, Chang, Lisa, LaVange, Michael, Proschan, Samuel A, Bozzette, William G, Powderly
Publikováno v:
medRxiv
BackgroundImmune dysregulation contributes to poorer outcomes in severe Covid-19. Immunomodulators targeting various pathways have improved outcomes. We investigated whether infliximab provides benefit over standard of care.MethodsWe conducted a mast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c636f160d614202fc158d1f4336836d
https://pubmed.ncbi.nlm.nih.gov/36172138
https://pubmed.ncbi.nlm.nih.gov/36172138
Autor:
Justin M, Vader, Michael M, Givertz, Randall C, Starling, Steven E, McNulty, Kevin J, Anstrom, Patrice, Desvigne-Nickens, Adrian F, Hernandez, Eugene, Braunwald, Douglas L, Mann
Publikováno v:
JACC. Heart failure. 10(7)
The LIFE (LCZ696 In Hospitalized Advanced Heart FailurE) trial, which evaluated sacubitril/valsartan in patients with advanced heart failure (HF) with reduced ejection fraction and recent New York Heart Association functional class IV symptomatology,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2e24102f82d4a74fdbe32a45cddc5cb3
https://pubmed.ncbi.nlm.nih.gov/35772854
https://pubmed.ncbi.nlm.nih.gov/35772854
Autor:
Kenneth B, Margulies, Adrian F, Hernandez, Margaret M, Redfield, Michael M, Givertz, Guilherme H, Oliveira, Robert, Cole, Douglas L, Mann, David J, Whellan, Michael S, Kiernan, G Michael, Felker, Steven E, McNulty, Kevin J, Anstrom, Monica R, Shah, Eugene, Braunwald, Thomas P, Cappola, M, Shah
Publikováno v:
JAMA. 316(5)
Importance Abnormal cardiac metabolism contributes to the pathophysiology of advanced heart failure with reduced left ventricular ejection fraction (LVEF). Glucagon-like peptide 1 (GLP-1) agonists have shown cardioprotective effects in early clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17936829348525afe793e6a2e1f7df3f
https://pubmed.ncbi.nlm.nih.gov/27959988
https://pubmed.ncbi.nlm.nih.gov/27959988
Autor:
Gust H. Bardy, Kerry L. Lee, Daniel B. Mark, Jeanne E. Poole, Douglas L. Packer, Robin Boineau, Michael Domanski, Charles Troutman, Jill Anderson, George Johnson, Steven E. McNulty, Nancy Clapp-Channing, Linda D. Davidson-Ray, Elizabeth S. Fraulo, Daniel P. Fishbein, Richard M. Luceri, John H. Ip
Publikováno v:
New England Journal of Medicine. 352:225-237
background Sudden death from cardiac causes remains a leading cause of death among patients with congestive heart failure (CHF). Treatment with amiodarone or an implantable cardioverter–defibrillator (ICD) has been proposed to improve the prognosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d5c502c9a1e27592679a5fc589ef3e4
https://doi.org/10.1056/nejmoa043399
https://doi.org/10.1056/nejmoa043399
Autor:
Horng H, Chen, Kevin J, Anstrom, Michael M, Givertz, Lynne W, Stevenson, Marc J, Semigran, Steven R, Goldsmith, Bradley A, Bart, David A, Bull, Josef, Stehlik, Martin M, LeWinter, Marvin A, Konstam, Gordon S, Huggins, Jean L, Rouleau, Eileen, O'Meara, W H Wilson, Tang, Randall C, Starling, Javed, Butler, Anita, Deswal, G Michael, Felker, Christopher M, O'Connor, Raphael E, Bonita, Kenneth B, Margulies, Thomas P, Cappola, Elizabeth O, Ofili, Douglas L, Mann, Víctor G, Dávila-Román, Steven E, McNulty, Barry A, Borlaug, Eric J, Velazquez, Kerry L, Lee, Monica R, Shah, Adrian F, Hernandez, Eugene, Braunwald, Margaret M, Redfield, Linda, Wick
Publikováno v:
JAMA. 310(23)
Small studies suggest that low-dose dopamine or low-dose nesiritide may enhance decongestion and preserve renal function in patients with acute heart failure and renal dysfunction; however, neither strategy has been rigorously tested.To test the 2 in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfa3be252cfd47e866fa2058521e4b20
https://pubmed.ncbi.nlm.nih.gov/24737372
https://pubmed.ncbi.nlm.nih.gov/24737372
Autor:
Margaret M. Redfield, Horng H. Chen, Barry A. Borlaug, Marc J. Semigran, Kerry L. Lee, Gregory Lewis, Martin M. LeWinter, Jean L. Rouleau, David A. Bull, Douglas L. Mann, Anita Deswal, Lynne W. Stevenson, Michael M. Givertz, Elizabeth O. Ofili, Christopher M. O’Connor, G. Michael Felker, Steven R. Goldsmith, Bradley A. Bart, Steven E. McNulty, Jenny C. Ibarra, Grace Lin, Jae K. Oh, Manesh R. Patel, Raymond J. Kim, Russell P. Tracy, Eric J. Velazquez, Kevin J. Anstrom, Adrian F. Hernandez, Alice M. Mascette, Eugene Braunwald, for the RELAX Trial
Publikováno v:
JAMA. 309(12)
Importance Studies in experimental and human heart failure suggest that phosphodiesterase-5 inhibitors may enhance cardiovascular function and thus exercise capacity in heart failure with preserved ejection fraction (HFPEF). Objective To determine th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5114a722f47bea42af654b296ba6c188
https://pubmed.ncbi.nlm.nih.gov/23917302
https://pubmed.ncbi.nlm.nih.gov/23917302
Autor:
L. Kristin Newby, Alan B. Storrow, W. Brian Gibler, J. Lee Garvey, John F. Tucker, Andrew L. Kaplan, Donald H. Schreiber, Robert H. Tuttle, Steven E. McNulty, E. Magnus Ohman
Publikováno v:
Circulation. 103(14)
Background —Earlier, rapid evaluation in chest pain units may make patient care more efficient. A multimarker strategy (MMS) testing for several markers of myocardial necrosis with different time-to-positivity profiles also may offer clinical advan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::305486d78b02f3500f0fc910fa2af0f8
https://pubmed.ncbi.nlm.nih.gov/11723038
https://pubmed.ncbi.nlm.nih.gov/11723038